首页|子宫肌瘤微无创治疗的适应证和禁忌证

子宫肌瘤微无创治疗的适应证和禁忌证

扫码查看
子宫肌瘤是最常见的妇科疾病之一,有症状的子宫肌瘤需要进行临床治疗.由于药物治疗复发率高、症状缓解程度和持续时间有限,故常用于症状轻、手术治疗前预处理及拒绝或无法手术等情况,而其他有症状的子宫肌瘤仍需选择更有效的治疗方法.为了减少治疗所导致的创伤,临床上出现了多种子宫肌瘤的微无创治疗方法,主要包括微创手术,如腹腔镜下子宫肌瘤切除术或子宫切除术、阴式子宫肌瘤切除术或子宫切除术、宫腔镜下子宫肌瘤切除术等.此外,随着新型非手术微无创治疗技术的不断发展,血管介入治疗和聚焦超声消融手术等也应用于子宫肌瘤的临床治疗.文章就目前常见的子宫肌瘤微无创治疗方法的适应证和禁忌证进行阐述及总结,从而为子宫肌瘤临床治疗的决策选择提供参考.
Indications and contraindications of non-inva-sive and minimally invasive treatment for uter-ine fibroids
Uterine fibroids are one of the most common gynecological diseases,and symptomatic uterine fi-broids usually need clinical treatment.However,drug treatments have a high recurrence rate and offer limited relief in terms of both degree and duration of symptoms.As a result,these treatments are typically used for mild symptoms,as a pre-treatment before surgical options,or in cases where surgery is not feasible or desired.For more severe symptoms,alternative and more effective treatment methods are necessary.To minimize the trauma associated with treatments,various non-inva-sive and minimally invasive approaches have been developed in clinical practice.These include minimally invasive surgeries like laparoscopic myomectomy or hysterectomy,vaginal myomectomy or hysterectomy,and hysteroscopic myomectomy.In addition,with the advancements in non-surgical non-invasive and minimally invasive novel treatments,vascular inter-ventional therapy and focused ultrasound ablation surgery have been increasingly utilized in clinical settings.This paper aims to outline the indications and contraindications of common non-invasive and mini-mally invasive treatment methods for uterine fibroids,providing valuable insights for clinicians in making decisions regarding the treatment of uterine fibroids.

uterine fibroidsindicationscontraindi-cationslaparoscopyhysteroscopyfocused ultra-sound ablation surgeryuterine artery embolization

叶明珠、薛敏

展开 >

中南大学湘雅三医院妇科,湖南长沙 410013

子宫肌瘤 适应证 禁忌证 腹腔镜 宫腔镜 聚焦超声消融手术 子宫动脉栓塞术

湖南省自然科学基金

2021JJ31031

2024

中国实用妇科与产科杂志
中国医师协会 中国实用医学杂志社

中国实用妇科与产科杂志

CSTPCD北大核心
影响因子:1.97
ISSN:1005-2216
年,卷(期):2024.40(9)
  • 6